small molecule therapeutic for rheumatoid arthritis (Chang Zheng-Cinkate Pharmaceutical)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namesmall molecule therapeutic for rheumatoid arthritis (Chang Zheng-Cinkate Pharmaceutical)
Drug Alias Nametairuimide
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLupus Erythematosus, SystemicArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChangzheng Cinkate
China Registration ClassN/A

Develop Information

Active CompaniesChangzheng Cinkate
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, SystemicArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A